UVA critical wavelength method inadequate to predict potential UVA absorption -- L'Oreal.
This article was originally published in The Rose Sheet
Executive Summary
UVA CRITICAL WAVELENGTH TEST "NOT ADEQUATE" FOR DETERMINING UVA EFFICACY, L'OREAL maintains in May 15 comments to FDA on the sunscreen tentative final monograph. Following a study evaluation of the proposed in vitro critical wavelength method, L'Oreal found the test "does not provide a quantitative measure of the UVA protection afforded" by a sunscreen. "Since this method does not account for any biological response, it cannot adequately predict a product's protection against UVA effects on the skin," the company states. L'Oreal is working on an alternative testing method to measure UVA protection in sunscreens.